https://orcid.org/0000-0002-3879-0904
References
- Buchman AS, Shah RC, Leurgans SE, et al. Musculoskeletal pain and incident disability in community-dwelling older adults. Arthritis Care Res (Hoboken). 2010;62:1287–1293.
- Baron R, Binder A, Wasner G. Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol. 2010;9:807–819.
- Ushida T, Matsui D, Inoue T, et al. Recent prescription status of oral analgesics in Japan in real-world clinical settings: retrospective study using a large-scale prescription database. Expert Opin Pharmacother. 2019;20:2041–2052.
- Crichton B, Green M. GP and patient perspectives on treatment with non-steroidal anti-inflammatory drugs for the treatment of pain in osteoarthritis. Curr Med Res Opin. 2002;18:92–96.
- Bekkering GE, Bala MM, Reid K, et al. Epidemiology of chronic pain and its treatment in the Netherlands. Neth J Med. 2011;69:141–153.
- Treede RD, Rief W, Barke A, et al. Chronic pain as a symptom or a disease: the IASP classification of chronic pain for the International Classification of Diseases (ICD-11). Pain. 2019;160:19–27.
- World Medical Association (WMA). WMA declaration of Helsinki -ethical principles for medical research involving human subjects. [cited 2019 Feb 12]. Available from: https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/
- Act on the protection of personal information (Act No. 57 of 2003). [cited 2019 Oct 10]. Japanese. Available from: https://elaws.e-gov.go.jp/search/elawsSearch/elaws_search/lsg0500/detail?lawId=415AC0000000057
- Amended act on the protection of personal information (May 30, 2017). [cited 2019 Oct 10]. Japanese. Available from: https://elaws.e-gov.go.jp/search/elawsSearch/elaws_search/lsg0500/detail?lawId=415AC0000000057
- Ethical guidelines for medical and health research involving human subjects. [cited 2019 Oct 10]. Available from: https://www.mhlw.go.jp/file/06-Seisakujouhou-10600000-Daijinkanboukouseikagakuka/0000080278.pdf
- Ogawa S. Development of new screening questionnaire to identify neuropathic components in Japanese patients with chronic pain. Pain Clinic. 2010;31:1187–1194. Japanese.
- Japan Society of Pain Clinicians, eds. Guidelines for the pharmacologic management of neuropathic pain. 2nd ed. Tokyo, Japan: Shinko Trading Co., Ltd.; 2016. [cited 2019 Oct 10]. Japanese/English (Japanese Guideline, p34, Figure 2/English Guideline, p156, Figure 2). Available from: http://minds4.jcqhc.or.jp/minds/Pharmacologic-management-of-neuropathic-pain/Pharmacologic-management-of-neuropathic-pain.pdf
- Pfizer Japan Inc. Status of chronic pain in 47 prefectures: a comparative study between 2012 and 2017. Reference Material. [ cited 2019 October 10]. Japanese. Available from: https://www.pfizer.co.jp/pfizer/company/press/2017/documents/2017082302.pdf
- Ogawa S, eds. Neuropathic pain. Tokyo, Japan: Nanzando Co., Ltd.; 2010. Japanese.
- Eli Lilly Japan K.K. Cymbalta (duloxetine) Capsules, package insert. Japanese. [cited 2019 May 24]. Available from: https://www.pmda.go.jp/PmdaSearch/iyakuDetail/ResultDataSetPDF/340018_1179052M1022_2_21
- NIPPON ZOKI Pharmaceutical Co., Ltd. Neurotropin tab. 4 N.U., package insert. Japanese. [cited 2019 Feb 12]. Available from: https://www.pmda.go.jp/PmdaSearch/iyakuDetail/ResultDataSetPDF/530288_1149023F1036_1_05